Nat. Chem. Biol. 6, 117–124 (2010); published online 10 January 2010; corrected after print 12 February 2010
In the version of this article initially published, Pingda Ren was inadvertently left off the author list. The error has been corrected in the author list, author contributions and conflict of financial interest declaration of the HTML and PDF versions of the article.
Additional information
The online version of the original article can be found at 10.1038/nchembio.293
Rights and permissions
About this article
Cite this article
Berndt, A., Miller, S., Williams, O. et al. Correction: Corrigendum: The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors. Nat Chem Biol 6, 244 (2010). https://doi.org/10.1038/nchembio0310-244b
Issue Date:
DOI: https://doi.org/10.1038/nchembio0310-244b
This article is cited by
-
PI3K inhibitors are finally coming of age
Nature Reviews Drug Discovery (2021)
-
Molecular insights into the membrane-associated phosphatidylinositol 4-kinase IIα
Nature Communications (2014)
-
PI3K and cancer: lessons, challenges and opportunities
Nature Reviews Drug Discovery (2014)
-
Activation of PI3Kα by physiological effectors and by oncogenic mutations: structural and dynamic effects
Biophysical Reviews (2014)
